PharmaShots | Incisive News in 3 Shots

Subscribe Now

Unclassifiable Interstitial Lung Disease

Roche Reports the US FDA's Acceptance of sNDA and Granted Priority Review for Esbriet (pirfenidone) to Treat UILD

Roche Reports the US FDA's Acceptance of sNDA and Granted Priority Review for Esbriet (pirfenidone) to Treat UILD

January 21, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us